Literature DB >> 21228221

Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells.

Julia Carracedo1, Ana Merino, Carolina Briceño, Sagrario Soriano, Paula Buendía, Laura Calleros, Mariano Rodriguez, Alejandro Martín-Malo, Pedro Aljama, Rafael Ramírez.   

Abstract

Carbamylated low-density lipoprotein (cLDL) plays a role in atherosclerosis. In this study we evaluate the effect of uremia on LDL carbamylation and the effect of cLDL and oxidized LDL (oxLDL; 200 μg/ml) on number, function, and genomic stability of endothelial progenitor cells (EPCs) obtained from healthy volunteers. cLDL was generated after incubation of native LDL (nLDL) with uremic serum from patients with chronic kidney disease (CKD) stages 2-4. Oxidative stress was measured by flow cytometry and fluorescent microscopy, mitochondrial depolarization by flow cytometry, senescence by β-galactosidase activity and telomere length, and DNA damage by phosphorylated histone H2AX (γH2AX). The percentage of cLDL by uremic serum was related to the severity of CKD. Compared with nLDL, cLDL induced an increase in oxidative stress (62±5 vs. 8±3%, P<0.001) and cells with mitochondrial depolarization (73±7 vs. 9±5%, P<0.001), and a decrease in EPC proliferation and angiogenesis. cLDL also induced accelerated senescence (73±16 vs. 12±9%, P<0.001), which was associated with a decrease in the expression of γH2AX (62±9 vs. 5±3%, P<0.001). The degree of injury induced by cLDL was comparable to that observed with oxLDL. This study supports the hypothesis that cLDL triggers genomic damage in EPCs, resulting in premature senescence. We can, therefore, hypothesize that EPCs injury by cLDL contributes to an increase in atherosclerotic disease in CKD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228221     DOI: 10.1096/fj.10-173377

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  30 in total

Review 1.  Ageing induced vascular smooth muscle cell senescence in atherosclerosis.

Authors:  Anna K Uryga; Martin R Bennett
Journal:  J Physiol       Date:  2015-09-16       Impact factor: 5.182

Review 2.  Aging and uremia: Is there cellular and molecular crossover?

Authors:  William E White; Muhammad M Yaqoob; Steven M Harwood
Journal:  World J Nephrol       Date:  2015-02-06

Review 3.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

Review 4.  Vascular Smooth Muscle Cells in Atherosclerosis.

Authors:  Martin R Bennett; Sanjay Sinha; Gary K Owens
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

5.  Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes.

Authors:  Joyita Banerjee; Swagata Roy; Yogita Dhas; Neetu Mishra
Journal:  Clin Exp Med       Date:  2019-11-15       Impact factor: 3.984

Review 6.  Remnant nephron physiology and the progression of chronic kidney disease.

Authors:  H William Schnaper
Journal:  Pediatr Nephrol       Date:  2013-05-29       Impact factor: 3.714

7.  Carbamylated-oxidized LDL: proatherosclerotic effects on endothelial cells and macrophages.

Authors:  Eugene O Apostolov; Ercan Ok; Samuel Burns; Safia Nawaz; Alena Savenka; Sudhir V Shah; Alexei G Basnakian
Journal:  J Atheroscler Thromb       Date:  2013-09-25       Impact factor: 4.928

Review 8.  Endothelial progenitor cells in atherosclerosis.

Authors:  Fuyong Du; Jun Zhou; Ren Gong; Xiao Huang; Meghana Pansuria; Anthony Virtue; Xinyuan Li; Hong Wang; Xiao-Feng Yang
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

9.  Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.

Authors:  Anders H Berg; Christiane Drechsler; Julia Wenger; Roberto Buccafusca; Tammy Hod; Sahir Kalim; Wenda Ramma; Samir M Parikh; Hanno Steen; David J Friedman; John Danziger; Christoph Wanner; Ravi Thadhani; S Ananth Karumanchi
Journal:  Sci Transl Med       Date:  2013-03-06       Impact factor: 17.956

Review 10.  Protein carbamylation in kidney disease: pathogenesis and clinical implications.

Authors:  Sahir Kalim; S Ananth Karumanchi; Ravi I Thadhani; Anders H Berg
Journal:  Am J Kidney Dis       Date:  2014-07-16       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.